Patrick Cox's Tech Digest

The Game of Science

April 3, 2017

Fogy, geezer, dotard, and fossil are just a few of the epithets aimed at older people who are assumed to be out of touch with the new. But the fact is, we’re all getting old. People who once looked down on the wrinkled and greying are enduring, in turn, the stigma of age.


Brit Billionaire Could Be the Biotech Tipping Point

March 27, 2017

We are in the midst of an unprecedented transformation. In the first part of the 21st century, advances in computer technology have dramatically increased the pace of biological sciences. In the previous century, life spans had already nearly doubled since the beginning of the 20th century. This trend will accelerate.


The Reason Why Fake News is Good News

March 13, 2017

I know many of us are still suffering from the artificial jet lag caused by the shift into daylight saving time (DST). At the same time, we’re also being bombarded with the concept of fake news. With that in mind, let’s take a look at the fake news about DST.


Here’s How Pharma Is Using AI Deep Learning to Cure Aging

March 6, 2017

In 2011, scientists made one of the most important discoveries in the history of AI development. They found that graphics processing units (GPUs) are far better at simulating biological learning than central processing units (CPUs).


Regeneration of Pancreas Is Big News for Diabetics and Biotech Investors

February 27, 2017

A paper published in the journal Cell has taken the scientific world by storm. Its premise is so transformational, it’s being discussed by nutritional biologists, biogerontologists, and stem cell scientists. Investors and life extension advocates also have good reason to take note.


This Company with Anti-Aging Drug Is Secretly Preparing for Trump’s New FDA

February 20, 2017

As Trump shakes up the White House, pharma and biotech are on edge. While the media talks about Obamacare, it turns out that Trump’s new FDA chief could have a bigger impact on health care and associated markets. The story here is that a company in liberal Northern California may have the most to gain from a Trump FDA.  


The Medical and Investment Ramifications of SCI Stem Cell Trial

February 6, 2017

Asterias Biotherapeutics (AST) continues to generate excitement and buzz around a transformative medical breakthrough. I wrote about this historic event back in September when the company first released results about its stem cell treatment for catastrophic spinal cord injury (SCI).


Black Swans, Barbells, and BioTech

January 30, 2017

Nassim Nicholas Taleb’s 2006 book, The Black Swan: The Impact of the Highly Improbable, popularized the view that societies have trouble dealing with big changes. Most people tend to think that things will go on pretty much as they have been… until they don’t.


Stay Up to Date!

Simply enter your email below and click SIGN UP!

Sort By Date

From Bioscience Expert Patrick Cox - The Most Life-Changing Book You'll Read This Year - Click Here
From Bioscience Expert Patrick Cox - The Most Life-Changing Book You'll Read This Year - Click Here